ZOLI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 3.442
AS - Asia 2.383
EU - Europa 1.063
SA - Sud America 478
AF - Africa 52
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.456
Nazione #
US - Stati Uniti d'America 3.337
SG - Singapore 849
CN - Cina 738
BR - Brasile 407
IT - Italia 365
HK - Hong Kong 258
DE - Germania 181
VN - Vietnam 170
TR - Turchia 168
UA - Ucraina 139
GB - Regno Unito 99
RU - Federazione Russa 74
MX - Messico 54
ID - Indonesia 50
CA - Canada 42
FI - Finlandia 41
IN - India 41
AU - Australia 34
PL - Polonia 33
AR - Argentina 32
NL - Olanda 30
ZA - Sudafrica 28
SE - Svezia 22
BD - Bangladesh 18
IR - Iran 17
ES - Italia 14
EC - Ecuador 12
AT - Austria 11
IQ - Iraq 11
LT - Lituania 11
CZ - Repubblica Ceca 9
MA - Marocco 9
PY - Paraguay 9
CO - Colombia 8
FR - Francia 8
JP - Giappone 7
TW - Taiwan 7
UZ - Uzbekistan 6
EG - Egitto 5
MY - Malesia 5
PH - Filippine 5
PK - Pakistan 5
AZ - Azerbaigian 4
RS - Serbia 4
SA - Arabia Saudita 4
BE - Belgio 3
CH - Svizzera 3
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
KR - Corea 3
KZ - Kazakistan 3
NG - Nigeria 3
NP - Nepal 3
PE - Perù 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DK - Danimarca 2
HN - Honduras 2
KG - Kirghizistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
CL - Cile 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GY - Guiana 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
OM - Oman 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.456
Città #
Singapore 502
Ashburn 485
Fairfield 479
Santa Clara 327
Hong Kong 258
Beijing 252
Woodbridge 211
Seattle 198
Wilmington 167
Cambridge 158
Izmir 157
Houston 154
Nanjing 78
Ho Chi Minh City 73
Princeton 69
Ann Arbor 63
Jacksonville 56
Munich 54
Dallas 51
Los Angeles 48
New York 46
São Paulo 41
Boardman 40
Mexico City 40
Milan 40
Hanoi 37
Jakarta 34
Bologna 31
Warsaw 31
London 30
Rome 30
Shanghai 30
San Diego 27
Shenyang 26
Chandler 23
Helsinki 23
Bremen 20
Chicago 19
Florence 18
Nanchang 18
Ferrara 17
Hebei 17
Jinan 17
Tianjin 17
Turku 15
Changsha 13
Imola 13
Jiaxing 13
Johannesburg 13
Brooklyn 12
Guangzhou 12
Melbourne 12
Norwalk 12
Rio de Janeiro 12
Montreal 11
Sydney 11
Toronto 11
Turin 11
Denver 10
Frankfurt am Main 10
Moscow 10
Nuremberg 10
Palermo 10
Belo Horizonte 9
Falls Church 9
Ottawa 9
Stockholm 9
Atlanta 8
Brasília 8
Brno 8
Council Bluffs 8
Mountain View 8
Porto Alegre 8
Reggio Nell'emilia 8
Taizhou 8
Verona 8
Zhengzhou 8
Augusta 7
Carapicuíba 7
Chennai 7
Falkenstein 7
Haiphong 7
Hefei 7
Modena 7
Mumbai 7
Phoenix 7
Tampa 7
Amsterdam 6
Bengaluru 6
Boston 6
Bắc Ninh 6
Haikou 6
Kunming 6
Lanzhou 6
Orem 6
Perth 6
Quito 6
Redwood City 6
San Francisco 6
Baghdad 5
Totale 4.996
Nome #
Sindrome di Budd-Chiari a decorso fatale in paziente con policitemia vera e sindrome da anticorpi antifosfolipidi [Sindrome di Budd-Chiari a decorso fatale in paziente con policitemia vera e sindrome da anticorpi antifosfolipidi] 222
Effects of Ethanol on the Digestive System: A Narrative Review 196
Alcohol Hub: il trattamento farmacologico dei disordini da uso di alcol 193
Splenic autotransplantation after splenectomy: Tuftsin activity correlates with residual splenic function 176
Randomised controlled trial of mesalazine in IBS 165
A brief up-date of the use of sodium oxybate for the treatment of alcohol use disorder 156
Osteoporosis in Celiac Disease: An Update 141
Sindrome da astinenza protratta da alcol: il ruolo del sodio ossibato...e non solo 141
Alcohol use disorders in the elderly: A brief overview from epidemiology to treatment options 138
Nutritional Treatment in Crohn’s Disease 137
Cardiac involvement in Crohn's disease: Echocardiographic study 135
Alcohol use in patients with chronic liver disease 132
A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse 131
Alcohol use disorder and GABAB receptor gene polymorphisms in an Italian sample: haplotype frequencies, linkage disequilibrium and association studies 123
Beyond biologics: advanced therapies in inflammatory bowel diseases 123
Effect of gluten-free diet on gut microbiota composition in patients with celiac disease and non-celiac gluten/wheat sensitivity 122
A reassessment of splenic hypofunction in celiac disease 119
The course of inflammatory bowel disease during pregnancy and postpartum: A prospective European ECCO-EpiCom Study of 209 pregnant women 118
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE) 117
Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau 116
An evaluation of factors affecting helicobacter pylori prevalence in tibetans exiled in india 116
Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity 115
Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series 115
Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA) 114
Treatment of alcohol-use disorders 113
Evidence-based decision for pharmacological management of alcoholic liver disease and alcohol dependence 112
Life-threatening onset of coeliac disease: A case report and literature review 112
Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study 111
Impaired splenic function and tuftsin deficiency in patients with intestinal failure on long term intravenous nutrition 110
Plasma Norepinephrine, Weak Neurotransmitters, and Renin Activity During Active Tilting in Liver Cirrhosis: Relationship with Cardiovascular Homeostasis and Renal Function 106
Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: A review 106
Treatment of narcolepsy with cataplexy 105
A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease 104
Mortality risk in a cohort of Italian alcoholic individuals treated for alcohol dependence 104
Increased resting lipid oxidation in Crohn's disease 99
Promotion of gallbladder emptying by intravenous aminoacids 97
Recurrent myocarditis in a patient with active ulcerative colitis: A case report and review of the literature 97
Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA) 97
Subclinical coeliac disease: an anthropometric assessment 96
Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: A pilot study 96
Alcohol use disorders and liver fibrosis: an update 93
Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: An open comparative study 92
Cytophilic antibodies cause leucocyte migration inhibition in coeliac disease 91
Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome 90
CLINICAL APPLICATIONS OF SCANNING ELECTRON MICROSCOPY IN GASTROINTESTINAL DISEASES 89
Defective phagocyte activity in adult coeliac disease 89
Changes in peripheral blood lymphocytes and immune complexes in splenectomized patients: lack of correlation with residual splenic function 87
Therapeutic options for coeliac disease: What else beyond gluten-free diet? 87
Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review 80
Gastrointestinal involvement in anderson-fabry disease: A narrative review 80
Alcohol Use in Adults Reply 79
Gamma hydroxybutyric acid (GHB): A valid pharmacological opportunity for the treatment of alcohol dependence 79
Increased energy expenditure in growing adolescents with Crohn's disease 79
Use of pyridoxine-alpha-ketoglutarate (PAK) in hepatic encephalopathy 76
Osteoporosis and Celiac Disease: Updates and Hidden Pitfalls 73
Tuftsin deficiency in AIDS 71
Major gastrointestinal hemorrhage during anticoagulant therapy in patients with atrial fibrillation: When should treatment be resumed? [Emorragia gastrointestinale maggiore in corso di terapia anticoagulante nei pazienti con fibrillazione atriale: quando riprendere il trattamento? ] 70
Efficacy and safety of capsule endoscopy in octogenarian patients: a retrospective study 69
Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: Partial benefit by infiximab - A pilot study 69
Echocardiographic evaluation of anti-Tumor Necrosis Factor-α therapy with infliximab in patients without cardiac pathologies 69
Effect of arginine thiazolidinecarboxylate (ATCA)* * SULFILE is the trade name for arginine thiazolidinecarboxylate (200 mg vials) manufactured by Poli-Industria Chimica, Italy. on some clinical and functional parameters in cirrhotic patients 66
Failure of adrenergic system in the control of arterial pressure in cirrhosis. Role of weak neurotransmitters 62
S.E.M. study I: Gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs (aspirin, piroxicam) in man 62
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 62
Ultrastructural aspects of duodenal mucosa repair during treatment of peptic disease 61
Identification of harmful drinking in subjects who have had their driving license suspended due to alcohol use: a retrospective Italian study 61
S.E.M. study II. Protective effect of ranitidine against gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs 59
Ocular naevus and hyperaemia with dilation of the conjunctival vessels: An early manifestation of Crohn's disease? 59
Il trattamento farmacologico della dipendenza da alcol 59
Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial 57
Howell‐Jolly body counting as a measure of splenic function. A reassessment 57
Pseudothrombocytopenia clinical comment on 37 cases 56
Efficacy and safety of gamma-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: A case report 56
Famotidine and ranitidine in the prevention of duodenal ulcer 55
Symptoms of protracted alcohol withdrawal in patients with alcohol use disorder: a comprehensive systematic review 53
Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study 53
The recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorder 48
Totale 7.624
Categoria #
all - tutte 49.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.305
Totale 51.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021362 0 0 0 0 0 46 16 106 35 76 54 29
2021/2022404 22 33 4 24 10 30 24 34 16 73 18 116
2022/2023267 73 9 20 4 26 15 18 15 36 1 34 16
2023/2024387 10 19 10 18 26 15 6 15 10 17 44 197
2024/20251.774 57 92 170 97 210 207 37 68 185 321 172 158
2025/20262.491 372 223 464 663 702 67 0 0 0 0 0 0
Totale 7.624